Oregon Health and Science University: Hemorrhage trials

The registry lists 10 Hemorrhage studies with Oregon Health and Science University as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 1 1Phase 2 1Phase 4 6No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Tranexamic Acid to Reduce Contraceptive-related Bleeding Side EffectsCompletedNCT06000423Phase 4Results posted
• Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant UsersCompletedNCT04205929Phase 4Results posted
• Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition TrialCompletedNCT03318783Phase 1/2Results posted
• Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant UsersCompletedNCT02903121Phase 4Results posted
• Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)CompletedNCT02824224Phase 4Results posted
• Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant UsersCompletedNCT02070692Phase 4Results posted
• Sevoflurane as an Anesthetic During Dilation and Evacuation ProceduresCompletedNCT01048658Phase 4Results posted
• Oxytocin Receptor Expression in PregnancyActive, not recruitingNCT03907735
• Characterizing the Impact and Treatment of Reproductive Tract Bleeding on Women and Post-menarchal Girls With Bleeding DisordersCompletedNCT03834727
• Continuous Oral Contraceptives (COCs): Are Bleeding Patterns Dependent on the Hormones Given?CompletedNCT00120913Not applicable